Search bioRxiv⌕ Search

Biology subjects

Jaynes, J.

Publications and source records attributed to Jaynes, J..

2 recordsLinked to original sources

Shared binding sites for the chromosomal architectural protein Su(Hw) mediate physical interactions between Drosophila TAD boundaries

The head-to-tail pairing of the nhomie and homie boundaries is responsible for the formation of a stem-loop TAD (topologically associated domain) that encompasses the even-skipped (eve) gene and its regulatory elements. TAD boundaries like homie and nhomie have partner preferences and one mechanism thought to be important in linking compatible boundaries is shared binding sites for the same architectural protein. Both eve boundaries have a single binding site for the polydactyl zinc finger protein Su(Hw). Here we have investigated the role of the shared Su(Hw) sites in the long-distance regulation of a dual reporter by the eve enhancers. Consistent with this mechanism, we find that when the transgene nhomie or homie boundary has a mutation in the Su(Hw) binding site, reporter activation by the eve enhancers is severely compromised. Using MicroC we show the mutating the single Su(Hw) substantially weakens the ability of the nhomie and homie boundaries in the transgene to physically pair with the two endogenous eve boundaries. Su(Hw) binding sites are not, however, sufficient as the gypsy su(Hw) insulator is unable to support long-distance regulation. In a less demanding transvection assay mutations in the nhomie and homie Su(hw) site have only a modest effect on regulatory interactions. The eve boundaries can mediate transvection with the gypsy insulator; however. they are not compatible with the dCTCF Fab-8 boundary even in the transvection assay. Finally, we show that the regulatory and physical interactions of the nhomie boundary in the transgene and the two endogenous eve boundaries are incompatible with the popular cohesin-loop extrusion model.

genetics↗

A Novel CD206 Targeting Peptide Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice

Activated M2 polarized macrophages are drivers of pulmonary fibrosis in several clinical scenarios such as Acute Respiratory Disease Syndrome (ARDS) and Idiopathic Pulmonary Fibrosis (IPF), through the production of inflammatory and fibrosis-inducing cytokines. In this study, we investigated the effect of targeting the CD206 receptor with a novel fragment of a Host Defense Peptide (HDP), RP-832c to decrease cytokines that cause fibrosis. RP-832c selectively binds to CD206 on M2 polarized bone marrow derived macrophages (BMDM) in vitro, resulting in a time-dependent decrease in CD206 expression, and a transient increase in M1 marker TNF, which resolves over a 24hr period. To elucidate the antifibrotic effect of RP-832c, we used a murine model of bleomycin (BLM) -induced early-stage pulmonary fibrosis. RP-832c significantly reduced bleomycin-induced fibrosis in a dosage dependent manner, as well as decreased CD206, TGF-{beta}1 and -SMA expression in mouse lungs. Interestingly we did not observe any changes in the resident alveolar macrophage marker CD170 expression. Similarly, in an established model of lung fibrosis, RP-832c significantly decreased fibrosis in the lung, as well as significantly decreased inflammatory cytokines TNF, IL-6, IL-10, INF-{gamma}, CXCL1/2, and fibrosis markers TGF-{beta}1 and MMP-13. In comparison with FDA approved drugs, Nintedanib and Pirfenidone, RP-832c exhibited a similar reduction in fibrosis compared to Pirfenidone, and to a greater extent than Nintedanib, with no apparent toxicities observed on body weight or blood chemistry. In summary, RP-832c is a potential agent to mitigate the overactivity of M2 macrophages in pathogenesis several pulmonary fibrotic diseases, including SARS-CoV-2 induced lung fibrosis.

pathology↗